在动脉样硬化中使用硫酸
Cong Lu1, Li Wu1, Mu-Yao Tang1
1Research Laboratory of Translational Medicine, Hengyang Medical School, University of South China, Hengyang, Hunan 421001, People's Republic of China; Departments of Clinical Medicine, Hengyang Medical School, University of South China, Hengyang, Hunan 421001, People's Republic of China.
Toxicology letters
|July 6, 2023
概括
酸 (IS) 是一种尿素毒素,通过促进血管功能障碍,炎症和氧化应激,显著促进动脉样硬化 (AS) 的发展. 了解IS介导机制可能会揭示患有功能障碍的患者心血管疾病的新治疗点.
科学领域:
- 心血管研究研究心血管研究
- 腎臟病學 (nephrology) 是一種醫學專業.
- 血管生物学 血管生物学
背景情况:
- 动脉样硬化 (AS) 是一种进展性血管炎症疾病,具有复杂的发病因子.
- 尿素毒素,特别是硫酸 (IS),越来越多地与心血管并发症有关.
- 连接IS与AS的精确分子机制仍然不完全理解.
研究的目的:
- 审查氧硫酸 (IS) 的异原性作用.
- 阐明IS诱导的AS的潜在分子机制.
- 突出IS介导动脉样硬化中的关键病理事件.
主要方法:
- 文献综述侧重于硫酸和动脉样硬化.
- 对研究IS在血管内皮功能障碍,氧化应激,炎症,化和血栓形成中的作用的分析.
- 关于IS对泡细胞形成和动脉中枢病变的贡献的综合证据.
主要成果:
- 硫酸 (IS) 具有多种异构性作用,有助于血管内皮功能障碍.
- 它促进血管氧化应激,炎症,化和血栓形成.
- IS与动脉中介性病变和泡细胞形成有关,这是AS发展的关键事件.
结论:
- 氧化硫酸 (IS) 是动脉样硬化 (AS) 发展和进展的重要因素.
- 向IS介导途径可能为功能障碍患者的心血管疾病提供新的治疗策略.
- 对IS特异信号的进一步研究对于确定新的治疗点至关重要.
相关概念视频
Atherosclerosis I: Introduction
11
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
11
Inflammation
53.9K
Overview
53.9K
Coronary Artery Disease II: Pathophysiology
14
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
14
Atherosclerosis III: Management
13
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
13
Coronary Artery Disease I: Introduction
25
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
25
Ischemic Heart Disease: Overview
1.3K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.3K


